Focussing on volume led growth, not price led growth: Lal Path Labs

"We look forward to delivering normal rate of growth on the non Covid side, as it is the focus of what we would like to do"-- said Bharath Uppiliappan, CEO, Dr Lal Path Labs.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news